Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,816 | 500 | 87.3% |
| Travel and Lodging | $766.96 | 2 | 6.8% |
| Current or prospective ownership or investment interest | $602.25 | 1 | 5.4% |
| Education | $52.50 | 4 | 0.5% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axonics, Inc. | $1,863 | 38 | $0 (2024) |
| PFIZER INC. | $1,289 | 88 | $0 (2024) |
| ABBVIE INC. | $1,267 | 71 | $0 (2024) |
| Astellas Pharma US Inc | $970.50 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $863.66 | 35 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $641.87 | 34 | $0 (2024) |
| Physician Discoveries, LLC | $602.25 | 2 | $0 (2017) |
| Palette Life Sciences, Inc. | $434.80 | 5 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $376.86 | 17 | $0 (2024) |
| Dornier MedTech America, Inc | $341.60 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,543 | 72 | Axonics, Inc. ($1,076) |
| 2023 | $1,701 | 60 | Dornier MedTech America, Inc ($341.60) |
| 2022 | $1,645 | 69 | Palette Life Sciences, Inc. ($434.80) |
| 2021 | $1,108 | 63 | Axonics, Inc. ($279.90) |
| 2020 | $494.02 | 35 | Axonics Modulation Technologies, Inc. ($141.32) |
| 2019 | $1,115 | 57 | Astellas Pharma US Inc ($246.60) |
| 2018 | $1,008 | 83 | Janssen Biotech, Inc. ($228.85) |
| 2017 | $1,623 | 69 | Physician Discoveries, LLC ($602.25) |
All Payment Transactions
508 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/02/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $126.83 | General |
| Category: Urology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | LANTHEUS MEDICAL IMAGING, INC. | — | Food and Beverage | In-kind items and services | $31.19 | General |
| 11/06/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: HORMONE THERAPY | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: HORMONE THERAPY | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Urology | ||||||
| 10/09/2024 | Endo USA, Inc. | AVEED (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 4,747 | 6,912 | $671,851 | $290,056 |
| 2022 | 31 | 5,144 | 11,555 | $781,868 | $335,152 |
| 2021 | 29 | 5,226 | 7,474 | $659,169 | $294,830 |
| 2020 | 23 | 4,409 | 6,201 | $511,769 | $202,802 |
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 792 | 1,199 | $206,287 | $102,479 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 392 | 463 | $63,080 | $27,246 | 43.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 104 | 127 | $44,450 | $21,907 | 49.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 18 | 144 | $64,800 | $18,269 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 158 | 158 | $36,005 | $17,192 | 47.7% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2023 | 13 | 28 | $33,271 | $16,698 | 50.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 553 | 776 | $38,800 | $13,954 | 36.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 29 | 30 | $37,100 | $12,912 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 85 | 103 | $23,681 | $12,773 | 53.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 177 | $14,868 | $7,717 | 51.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 588 | 819 | $8,096 | $6,583 | 81.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 175 | 278 | $15,012 | $5,466 | 36.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 1,108 | 1,693 | $16,930 | $5,228 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $9,765 | $4,858 | 49.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 21 | 21 | $9,219 | $3,525 | 38.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 435 | 514 | $16,448 | $3,446 | 20.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 23 | 23 | $8,211 | $2,482 | 30.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 33 | 71 | $4,615 | $1,796 | 38.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 34 | $5,100 | $1,641 | 32.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $2,748 | $1,555 | 56.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 69 | $8,625 | $1,539 | 17.8% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 13 | 13 | $1,950 | $452.53 | 23.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 27 | 28 | $2,100 | $269.36 | 12.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 24 | $240.00 | $52.80 | 22.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 21 | 45 | $450.00 | $18.17 | 4.0% |
About Dr. Mark Passarella, MD
Dr. Mark Passarella, MD is a Urology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841279445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Passarella, MD has received a total of $11,237 in payments from pharmaceutical and medical device companies, with $2,543 received in 2024. These payments were reported across 508 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($9,816).
As a Medicare-enrolled provider, Passarella has provided services to 19,526 Medicare beneficiaries, totaling 32,142 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Charlottesville, VA
- Active Since 01/11/2006
- Last Updated 04/14/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841279445
Products in Payments
- Axonics (Device) $1,543
- XTANDI (Drug) $1,471
- PROVENGE (Drug) $641.87
- LUPRON DEPOT (Drug) $589.42
- ORGOVYX (Drug) $518.66
- ERLEADA (Drug) $477.28
- Axonics r-SNM System (Device) $421.22
- Erleada (Drug) $413.43
- Androgel (Drug) $350.23
- Dornier MedTech (Device) $341.60
- Nubeqa (Drug) $244.77
- Xtandi (Drug) $219.05
- MYRBETRIQ (Drug) $212.45
- GEMTESA (Drug) $180.52
- Lupron Depot (Drug) $166.08
- Myrbetriq (Drug) $155.66
- INTERSTIM ICON (Device) $146.31
- CAMCEVI (Drug) $120.34
- (815) Thiola (Drug) $110.39
- Lupron (Drug) $108.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Charlottesville
Mikel Gray, N.p, N.P
Urology — Payments: $98,876
Dr. Nicolas Ortiz, M.d, M.D
Urology — Payments: $58,598
Dr. Mei Tuong, Md, MD
Urology — Payments: $52,632
Dr. Kirsten Greene, M.d, M.D
Urology — Payments: $21,742
Jacqueline Zillioux, Md, MD
Urology — Payments: $13,623
Julian Fagerli, Md, MD
Urology — Payments: $11,993